Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial

Christopher J. Clarke; Ashley J. Snider

doi:10.1124/molpharm.124.000863

Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial

Christopher J. Clarke
, Ashley J. Snider

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	116-117
Number of pages	2
Journal	Molecular pharmacology
Volume	105
Issue number	3
DOIs	https://doi.org/10.1124/molpharm.124.000863
State	Published - Mar 1 2024
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Access to Document

10.1124/molpharm.124.000863

Cite this

@article{25b999e6726b47898d82bee42e114171,

title = "Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial",

author = "Clarke, \{Christopher J.\} and Snider, \{Ashley J.\}",

year = "2024",

month = mar,

day = "1",

doi = "10.1124/molpharm.124.000863",

language = "English (US)",

volume = "105",

pages = "116--117",

journal = "Molecular pharmacology",

issn = "0026-895X",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "3",

}

TY - JOUR

T1 - Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial

AU - Clarke, Christopher J.

AU - Snider, Ashley J.

PY - 2024/3/1

Y1 - 2024/3/1

UR - https://www.scopus.com/pages/publications/85185233045

UR - https://www.scopus.com/pages/publications/85185233045#tab=citedBy

U2 - 10.1124/molpharm.124.000863

DO - 10.1124/molpharm.124.000863

M3 - Editorial

C2 - 38360838

SN - 0026-895X

VL - 105

SP - 116

EP - 117

JO - Molecular pharmacology

JF - Molecular pharmacology

IS - 3

ER -

Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this